TSCA Draft Risk Assessment: Dichlorobenzenes Regulatory Impact

On August 10, 2026, the U.S. Environmental Protection Agency (EPA) published draft risk assessments for o-dichlorobenzene (o-DCB) and p-dichlorobenzene (p-DCB) under the Toxic Substances Control Act (TSCA). The EPA has preliminarily determined that these substances present unreasonable risks to human health under specific conditions of use, primarily through inhalation and dermal exposure during industrial manufacturing and processing. Procurement managers and formulators should review their current inventory and dependency on these chlorinated solvents, as these findings may precede more stringent risk management requirements.

Understanding the TSCA Draft Risk Assessment for Dichlorobenzenes

The EPA's ongoing evaluation under TSCA focuses on how chemical substances interact with human health and the environment during their entire life cycle. By identifying unreasonable risks for o-DCB and p-DCB, the agency is preparing the groundwork for potential new exposure limits, operational requirements, or usage restrictions. The primary exposure pathways identified include industrial manufacturing, laboratory processing, and consumer applications such as lubricants and solvent-based formulations.

Dichlorobenzenes are chlorinated aromatic hydrocarbons that have served as workhorses in industrial chemistry for decades. o-Dichlorobenzene is widely utilised as a high-boiling solvent for organic synthesis, a precursor for the production of pesticides and dyes, and as a degreasing agent for engine parts. Conversely, p-Dichlorobenzene is perhaps most recognised by the public for its use in moth repellents and deodorising blocks, though its industrial utility as an intermediate in the synthesis of polyphenylene sulphide (PPS) resins remains critical.

Under the TSCA framework, the EPA is mandated to conduct comprehensive risk evaluations that assess both hazard and exposure. For these specific isomers, the EPA’s draft assessments utilise updated modelling of human health toxicity, including potential systemic effects from chronic exposure. The findings suggest that existing industrial controls—though functional in some settings—may be insufficient to mitigate risks to workers when factoring in peak exposure scenarios. For those responsible for supply chain management, this is a critical period of assessment. The EPA is actively soliciting public comment until October 9, 2026. This window provides an essential opportunity for industry stakeholders to provide real-world usage data, worker activity patterns, and validation of existing engineering controls. If your organisation currently utilises these materials, contributing to the public docket is a strategic step in ensuring that final regulatory actions are informed by precise operational realities.

Strategic Implications for Sourcing and QA/QC

For procurement and QA/QC teams, the immediate priority is to audit existing dependencies. If your operations rely heavily on these solvents, it is prudent to evaluate safer alternatives or to bolster current environmental, health, and safety (EHS) protocols. While current supplies remain available, future shifts in regulation could impact availability or necessitate costly modifications to facility compliance standards.

To assist organisations in evaluating their current chemical portfolio, it is helpful to compare these substances against broader categories of halogenated solvents. Below is a comparison table highlighting how the current EPA scrutiny of dichlorobenzenes aligns with broader market risk factors for commonly used industrial solvents:

QA/QC laboratories must also ensure that all documentation remains current. Maintaining access to detailed Certificates of Analysis is essential, particularly as regulatory scrutiny intensifies. As procurement teams look to de-risk their supply chains, ensuring that your suppliers provide full traceability is paramount. Our team at Tech Serve Solutions remains committed to providing transparent documentation for all materials in our chemistry catalog. If you need to perform updated risk assessments on your specific workflows, you may find our molecular weight and solution preparation tools useful for recalculating your safety and compliance margins during this transition.

Beyond documentation, QA/QC managers should consider reviewing the efficacy of current personal protective equipment (PPE) protocols. Given the EPA’s emphasis on dermal exposure, glove permeability testing and solvent-resistant garment validation should be refreshed in light of these new draft findings.

Preparing for Future Regulatory Changes

The potential for new risk management rules means that engineering controls—such as closed-loop systems and upgraded ventilation—will likely face greater scrutiny. The EPA's move toward more restrictive exposure limits often triggers a cascade effect, where state-level regulations and industry standards follow suit to ensure compliance with the overarching federal mandate. Firms that proactively update their handling procedures not only protect their workforce but also position themselves more resiliently against future TSCA-driven mandates.

Proactive compliance should include:

1. Exposure Monitoring: Conducting industrial hygiene surveys to measure actual parts-per-million (ppm) exposure levels at the workstation level.
2. Ventilation Upgrades: Implementing or re-certifying local exhaust ventilation (LEV) systems to ensure air turnover rates meet the latest safety standards for chlorinated aromatics.
3. Inventory Management: Implementing a "Just-in-Time" (JIT) procurement strategy for dichlorobenzenes to reduce the volume of stored hazardous chemicals on-site, thereby lowering the risk of accidental release and simplifying inventory control.
4. Employee Training: Updating training modules to include the latest findings from the 2026 draft assessments, ensuring that operators understand the long-term health risks associated with chronic, low-level exposure.

We advise all sourcing partners to monitor the EPA Dockets directly for updates on these specific chemicals. The regulatory landscape under TSCA is dynamic; therefore, maintaining an agile approach to solvent management is essential for long-term operational success.

As you navigate these potential shifts in the regulatory landscape, our team is available to discuss your specific requirements. We assist in sourcing reliable, high-grade reagents that meet rigorous industry standards. Understanding the difference between high-purity industrial grades and specialised lab-grade reagents is key when re-evaluating processes to accommodate new safety thresholds.

Please contact our specialist team if you have questions regarding the procurement of compliant alternatives or if you require documentation support for your internal quality audits. Our specialists can provide technical data sheets (TDS) and safety data sheets (SDS) that reflect the most current regulatory guidance, helping you maintain a seamless transition should you choose to switch to less volatile or lower-risk solvent alternatives. For further reading on industry standards, visit our full blog archive. By staying informed and preparing early, you can safeguard your laboratory and manufacturing processes against the uncertainty of upcoming regulatory shifts.